Vitreoretinal Surgery Devices Market By Product , By Surgery Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

Vitreoretinal Surgery Devices

The vitreoretinal surgery devices market was valued at $2.3 billion in 2023 and is projected to reach $4.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Vitreoretinal surgery devices are the specialized equipment essential to perform ophthalmic surgeries focused on retina and vitreous humor of eyes. Diverse retinal conditions such as macular holes, retinal detachments, diabetic retinopathy, and epiretinal membranes are treated using these devices for the repair & restoration of the normal anatomy and function of the eyes. Innovations in devices allow surgeries to be performed with minimal invasion, hence lowering the recovery times and improving patient outcomes.

Increase in the prevalence of eye surgeries, particularly among the old generation, is a key driver of the vitreoretinal surgery devices market. In addition, rise in expenditure by the government toward healthcare facilities has led to advancements in the vitreoretinal surgery devices, which is boosting their adoption in the healthcare settings. Currently, the integration of robotics technology into surgery devices is an emerging trend in the market. The technology exceeds human skills in such complex surgeries, reducing the possibility of errors and enhancing the precision. The researchers aim to create smart surgery procedures by the assimilation of robotics and AI.

However, the high upfront costs of procuring the vitreoretinal surgery devices, along with their maintenance requirements deters various small-scale healthcare facilities from investing in them. This restrains the market growth in various developing and underserved regions. Contrarily, the constantly rising numbers of eye conditions are projected to boost the adoption of vitreoretinal surgery devices in the future. According to a factsheet released by Bright Focus Foundation on October 2022, approximately 11 million individuals in the U.S. suffer from some form of age-related macular degeneration. The foundation anticipates the number to double to nearly 22 million by 2050, hence compelling the use of the devices for treatment.

Segment Review

The vitreoretinal surgery devices market is segmented into product, surgery type, end user, and region. On the basis of product, the market is divided into perfluorocarbon liquids, endoillumination instrument, vitreoretinal prefilled silicone oil syringes, vitrectomy system, and other. Depending on surgery type, the market is bifurcated into anterior vitreoretinal surgery and posterior vitreoretinal surgery. As per end user, it is categorized into hospitals, specialty clinics, and ambulatory surgery centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the vitrectomy system segment dominated the market in 2023.

Depending on surgery type, the anterior vitreoretinal surgery segment acquired a high stake at the market in 2023.

As per end user, the hospitals segment accounted for a high market share in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global vitreoretinal surgery devices market include Bausch & Lomb, Novartis AG, Inami & Co, Paragon Care Group Pty Ltd, Oculus Inc, MedOne Surgical, Inc, Carl Zeiss Meditec AG, Peregrine Surgical, Johnson & Johnson, and Blink Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

Perfluorocarbon Liquids
Endoillumination Instrument
Vitreoretinal Prefilled Silicone Oil Syringes
Vitrectomy System
Other

By Surgery Type

Anterior Vitreoretinal Surgery
Posterior Vitreoretinal Surgery

By End User

Hospitals
Specialty Clinics
Ambulatory Surgery Centers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Bausch & Lomb
Novartis AG
Inami & Co
Paragon Care Group Pty Ltd
Oculus Inc
MedOne Surgical, Inc
Carl Zeiss Meditec AG
Peregrine Surgical
Johnson & Johnson
Blink Medical

Product Code: A00914

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: VITREORETINAL SURGERY DEVICES MARKET, BY PRODUCT

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
4.2. Perfluorocarbon Liquids
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Endoillumination Instrument
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Vitreoretinal Prefilled Silicone Oil Syringes
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
4.5. Vitrectomy System
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
4.6. Other
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country

CHAPTER 5: VITREORETINAL SURGERY DEVICES MARKET, BY SURGERY TYPE

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Surgery Type
5.2. Anterior Vitreoretinal Surgery
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Posterior Vitreoretinal Surgery
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country

CHAPTER 6: VITREORETINAL SURGERY DEVICES MARKET, BY END USER

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Specialty Clinics
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Ambulatory Surgery Centers
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country

CHAPTER 7: VITREORETINAL SURGERY DEVICES MARKET, BY REGION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Surgery Type
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Vitreoretinal Surgery Devices Market
  - 7.2.6.1. Market Size and Forecast, By Product
  - 7.2.6.2. Market Size and Forecast, By Surgery Type
  - 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Vitreoretinal Surgery Devices Market
  - 7.2.7.1. Market Size and Forecast, By Product
  - 7.2.7.2. Market Size and Forecast, By Surgery Type
  - 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Vitreoretinal Surgery Devices Market
  - 7.2.8.1. Market Size and Forecast, By Product
  - 7.2.8.2. Market Size and Forecast, By Surgery Type
  - 7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Surgery Type
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Vitreoretinal Surgery Devices Market
  - 7.3.6.1. Market Size and Forecast, By Product
  - 7.3.6.2. Market Size and Forecast, By Surgery Type
  - 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Vitreoretinal Surgery Devices Market
  - 7.3.7.1. Market Size and Forecast, By Product
  - 7.3.7.2. Market Size and Forecast, By Surgery Type
  - 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Vitreoretinal Surgery Devices Market
  - 7.3.8.1. Market Size and Forecast, By Product
  - 7.3.8.2. Market Size and Forecast, By Surgery Type
  - 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Vitreoretinal Surgery Devices Market
  - 7.3.9.1. Market Size and Forecast, By Product
  - 7.3.9.2. Market Size and Forecast, By Surgery Type
  - 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Vitreoretinal Surgery Devices Market
  - 7.3.10.1. Market Size and Forecast, By Product
  - 7.3.10.2. Market Size and Forecast, By Surgery Type
  - 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest of Europe Vitreoretinal Surgery Devices Market
  - 7.3.11.1. Market Size and Forecast, By Product
  - 7.3.11.2. Market Size and Forecast, By Surgery Type
  - 7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Surgery Type
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Vitreoretinal Surgery Devices Market
  - 7.4.6.1. Market Size and Forecast, By Product
  - 7.4.6.2. Market Size and Forecast, By Surgery Type
  - 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Vitreoretinal Surgery Devices Market
  - 7.4.7.1. Market Size and Forecast, By Product
  - 7.4.7.2. Market Size and Forecast, By Surgery Type
  - 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. Australia Vitreoretinal Surgery Devices Market
  - 7.4.8.1. Market Size and Forecast, By Product
  - 7.4.8.2. Market Size and Forecast, By Surgery Type
  - 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. India Vitreoretinal Surgery Devices Market
  - 7.4.9.1. Market Size and Forecast, By Product
  - 7.4.9.2. Market Size and Forecast, By Surgery Type
  - 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Vitreoretinal Surgery Devices Market
  - 7.4.10.1. Market Size and Forecast, By Product
  - 7.4.10.2. Market Size and Forecast, By Surgery Type
  - 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Vitreoretinal Surgery Devices Market
  - 7.4.11.1. Market Size and Forecast, By Product
  - 7.4.11.2. Market Size and Forecast, By Surgery Type
  - 7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Surgery Type
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Vitreoretinal Surgery Devices Market
  - 7.5.6.1. Market Size and Forecast, By Product
  - 7.5.6.2. Market Size and Forecast, By Surgery Type
  - 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Vitreoretinal Surgery Devices Market
  - 7.5.7.1. Market Size and Forecast, By Product
  - 7.5.7.2. Market Size and Forecast, By Surgery Type
  - 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Vitreoretinal Surgery Devices Market
  - 7.5.8.1. Market Size and Forecast, By Product
  - 7.5.8.2. Market Size and Forecast, By Surgery Type
  - 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Vitreoretinal Surgery Devices Market
  - 7.5.9.1. Market Size and Forecast, By Product
  - 7.5.9.2. Market Size and Forecast, By Surgery Type
  - 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Bausch And Lomb
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
9.2. Novartis AG
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
9.3. Inami And Co
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
9.4. Paragon Care Group Pty Ltd
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
9.5. Oculus Inc
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
9.6. MedOne Surgical, Inc
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
9.7. Carl Zeiss Meditec AG
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
9.8. Peregrine Surgical
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
9.9. Johnson And Johnson
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
9.10. Blink Medical
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments